High dose chemoradiotherapy increases chance of organ preservation with satisfactory functional outcome for rectal cancer

Table 2 Treatment information, acute adverse events and response to therapy

Characteristic	No. of patients (%)
Courses of radiotherapy
One course	11 (19.3)
Two courses	46 (80.7)
Dose of radiotherapy
Median, Gy (range)	80 (60–86)
Radiation technology
3D-CRT	7 (12.3)
IMRT	50 (87.7)
Chemotherapy regime
mFolfox6	2 (3.5)
CapeOX	37 (64.9)
Capecitabine	18 (31.6)
Cycles of chemotherapy
Median (range)	8 (1–11)
Grade 3–4 complications during treatment
Any types	18 (31.6)
Proctitis	6 (10.5)
Diarrhea	2 (3.5)
Dermatitis associated with radiation	7 (12.3)
Leukopenia	4 (7.0)
Thrombocytopenia	6 (10.5)
Response to treatment
cCR	42 (73.7)
Non-cCR	15 (26.3)

3D-CRT three-dimensional conformal radiation therapy, IMRT intensity-modulated radiation therapy, cCR clinical complete response

ISSN: 1748-717X